Western media has perpetuated society’s perspective of the nursing role through a sexual lens rather than a professional. Nurses face high levels of sexual harassment and violence, with some studies showing up to 80% of nurses experiencing some form of sexual harassment in the workplace at some point in their career. The relationship between the media’s sexualization of nurses has led to an increase in harassment and violence in the profession, as well as proliferating the stereotype of ‘sexy nurses.’ In this literature review, I examine both the media and cultural perception of the nurse and the data surrounding sexual harassment and violence of nurses in the workplace. We know that workplace harassment can lead to increased rates of burnout and staff turnover, if the image of nursing is changed then we can create a healthier work environment with higher levels of job satisfaction and safety.

The prevalence of food allergies in the United States has increased dramatically, affecting 4 in every 100 children under the age of 18. There are 8 main categories of food that make up the most common food allergies. These foods include eggs, fish, milk, crustacean shellfish, wheat, tree nuts, soy, sesame, and peanuts. Together, these foods create the "Big 8" list: a priority list for the US Food Allergen Labeling and Consumer Protection Act (FALCPA). In this literature review of current treatments for food allergies, we will select the peanut allergy for further research due to the often fatal complications that arise from anaphylaxis following exposure. This review will seek to provide a comprehensive overview of the current types of food allergy treatments and to discuss a cure for peanut allergies. The current solutions available today to treat food-induced allergic reactions include medical treatment (epinephrine), immunotherapy (e.g., "allergy shots'), nutritional support, and simply avoidance. While these solutions are great aids to help alleviate allergic reactions, they do not cure the food allergies themselves. This means that people who have food allergies are not able to consume the foods they want or need. This begs the question, "Is it possible to make a cure for peanut allergies?" The origin of food-induced intolerances stems from the failure of the immune system to ignore, or be tolerant of, food antigens. Previous studies have identified specific peanut antigens that promote allergic responses. Food allergic immune responses are primarily driven by T cells. Potentially, these antigens can be used to isolate peanut-specific T cells in allergic individuals. These T cells could then be analyzed and used to generate cell-based therapies to suppress allergic responses (bystander suppression). This solution could permanently prevent peanut-induced allergic reactions from occurring. 

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) occurs when a streptococcal infection triggers an abnormal immune response, leading to neuroinflammation in the basal ganglia, causing sudden-onset OCD and other neuropsychiatric symptoms. Current treatments include antibiotics, cognitive-behavioral therapy, selective serotonin reuptake inhibitors, and anti-inflammatory medications (NSAIDs, corticosteroids). While antibiotics target infection, they often fail to resolve persistent immune dysfunction. Some patients experience recurring symptoms, suggesting an autoimmune-driven mechanism beyond direct infection. Despite growing research, PANDAS remains controversial. Some clinicians support an autoimmune model, linking streptococcal infections to neuropsychiatric symptoms; others argue that evidence is inconclusive or that PANDAS is not a distinct disorder. Skeptics cite inconsistent diagnostic criteria, patient variability, and limited large-scale clinical trials. Additionally, the lack of a clear biomarker and symptom overlap with other childhood-onset OCD and tic disorders create diagnostic uncertainty. Intravenous Immunoglobulin (IVIG) has shown promise in modulating immune responses, reducing autoantibody activity, and lowering neuroinflammation, offering a complementary therapy. However, placebo-controlled trials remain limited, and the synergy between IVIG and antibiotics remains underexplored. This literature review seeks to fill that gap, evaluating the combined efficacy of IVIG and antibiotics in treating PANDAS-associated OCD. It examines whether dual therapy leads to better clinical outcomes than monotherapy and identifies which antibiotics work best with IVIG. Drawing from existing studies on similar conditions and neuroinflammatory mechanisms, this research synthesizes clinical trials, case studies, and immune-response data to explore the therapeutic synergy of these treatments. Preliminary evidence suggests IVIG and antibiotics together may better address both infectious and immune components, potentially improving outcomes. However, further research is needed to optimize treatment protocols, refine diagnostic criteria, and expand knowledge on immune-brain interactions in pediatric neuropsychiatric disorders. Future implications include refining diagnostic criteria, identifying biomarkers, and expanding research on the immune-brain connection in pediatric neuropsychiatric disorders.